Defunct Company
Total Trials
11
As Lead Sponsor
8
As Collaborator
3
Total Enrollment
4,629
NCT00530881
Randomized, Double-Blind, Placebo-Controlled, With PHX1149 in Patients With Type 2 Diabetes Mellitus
Phase: Phase 2
Role: Lead Sponsor
Start: Apr 30, 2006
Completion: Oct 31, 2006
NCT00482950
A Study to Evaluate Safety and Efficacy of PHX1149T in Subjects With Type 2 Diabetes Mellitus
Start: Apr 30, 2007
Completion: Feb 29, 2008
NCT01101945
Long-term Extension Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus
Start: Jul 31, 2007
Completion: Mar 31, 2010
NCT00690638
Safety and Efficacy Study of Dutogliptin/PHX1149T to Treat Type 2 Diabetes Mellitus
Phase: Phase 3
Start: Jul 31, 2008
Completion: Apr 30, 2010
NCT00865592
Long-term Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus
Start: Mar 31, 2009
Completion: Mar 31, 2011
NCT00850239
Safety and Efficacy Study of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin
Start: May 31, 2009
Completion: Dec 31, 2010
NCT00947557
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin
Role: Collaborator
Start: Jul 31, 2009
Completion: Not specified
NCT00958269
Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal Impairment
Start: Aug 31, 2009
Completion: Nov 30, 2011
NCT00970424
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone
NCT00998686
Safety and Efficacy Study of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin
Start: Nov 30, 2009
NCT01089790
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone
Start: Mar 31, 2010